2022
DOI: 10.3389/fbioe.2022.921107
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Small-Molecule Inhibitors for Osteosarcoma Targeted Therapy: Synchronizing In Silico, In Vitro, and In Vivo Analyses

Abstract: Objective: The study aimed to explore a new approach for the treatment of osteosarcoma through combining biomaterials with next-generation small molecule–based targeted therapy.Methods: The model of osteosarcoma was established by 4-hydroxyaminoquinoline 1-oxide (4-HAQO) in mice while the collagen-thermosensitive hydrogel–calcium phosphate (CTC) biocomposites were prepared, and the small molecule inhibitors were virtually screened and synthesized. Then, for the osteosarcoma cell line, MG-63 cells were used to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Targeted therapies for OS have garnered interest, with small-molecule targeted inhibitors emerging as one of the most promising avenues ( 7 ). mTOR, a serine/threonine protein kinase, serves a pivotal role in regulating cell proliferation, differentiation, senescence and metabolism ( 8 - 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…Targeted therapies for OS have garnered interest, with small-molecule targeted inhibitors emerging as one of the most promising avenues ( 7 ). mTOR, a serine/threonine protein kinase, serves a pivotal role in regulating cell proliferation, differentiation, senescence and metabolism ( 8 - 10 ).…”
Section: Introductionmentioning
confidence: 99%